Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Moss

Showing results (221-230 of 308) with videos related to

Pageof 31
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutantsAndrea S Weisberg, Liliana Maruri-Avidal, Himani Bisht, et al.
Protein Expression and Purification|September 26, 2007
High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus AnkaraMatthias Hebben, Jan Brants, Catherine Birck, et al.
Viral Immunology|January 5, 2007
T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cellsLeon de Waal, Yasemin Süzer, Linda S Wyatt, et al.
Journal of Virology|February 26, 2005
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2Shanmugalakshmi Sadagopal, Rama Rao Amara, David C Montefiori, et al.
Journal of Virology|March 30, 2004
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocolElizabeth Ramsburg, Nina F Rose, Preston A Marx, et al.
Journal of Virology|April 29, 2005
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5RLydia Aldaz-Carroll, J Charles Whitbeck, Manuel Ponce de Leon, et al.
Nature Microbiology|June 10, 2026
Immunogenicity of poxvirus A16/G9 entry-fusion subcomplex and its restriction by A56/K2 protein informs vaccine designHuibin Yu, Wolfgang Resch, Catherine A Cotter, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Antibody Binding and Neutralizing Targets within the Predicted Structure of the Poxvirus Multiprotein Entry-Fusion ComplexHuibin Yu, Wolfgang Resch, Catherine A Cotter, et al.
Vaccine|January 19, 2007
Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesChristiana N Fogg, Jeffrey L Americo, Shlomo Lustig, et al.
AIDS Research and Human Retroviruses|December 28, 2007
Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cellsHarriet L Robinson, Sunita Sharma, Jun Zhao, et al.
Pageof 31

Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutantsAndrea S Weisberg, Liliana Maruri-Avidal, Himani Bisht, et al.
Protein Expression and Purification|September 26, 2007
High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus AnkaraMatthias Hebben, Jan Brants, Catherine Birck, et al.
Viral Immunology|January 5, 2007
T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cellsLeon de Waal, Yasemin Süzer, Linda S Wyatt, et al.
Journal of Virology|February 26, 2005
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2Shanmugalakshmi Sadagopal, Rama Rao Amara, David C Montefiori, et al.
Journal of Virology|March 30, 2004
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocolElizabeth Ramsburg, Nina F Rose, Preston A Marx, et al.
Journal of Virology|April 29, 2005
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5RLydia Aldaz-Carroll, J Charles Whitbeck, Manuel Ponce de Leon, et al.
Nature Microbiology|June 10, 2026
Immunogenicity of poxvirus A16/G9 entry-fusion subcomplex and its restriction by A56/K2 protein informs vaccine designHuibin Yu, Wolfgang Resch, Catherine A Cotter, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Antibody Binding and Neutralizing Targets within the Predicted Structure of the Poxvirus Multiprotein Entry-Fusion ComplexHuibin Yu, Wolfgang Resch, Catherine A Cotter, et al.
Vaccine|January 19, 2007
Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesChristiana N Fogg, Jeffrey L Americo, Shlomo Lustig, et al.
AIDS Research and Human Retroviruses|December 28, 2007
Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cellsHarriet L Robinson, Sunita Sharma, Jun Zhao, et al.
Pageof 31